Pepscan is a premier provider of peptide based products & services. We also offer our profound knowledge of peptides for drug discovery collaborations.

Pepscan is specialized in constrained peptides, and is the inventor of the CLIPS™ constraining technology. Our CLIPS peptides represent a new generation of biotherapeutics, offering antibody-like affinity and selectivity in a small, fully synthetic molecule.

Since June 2022 Pepscan has become a part of Biosynth Carbosynth (“Biosynth”), a provider of complex chemical products and manufacturing services to the life science industry.

Keep informed about news products, publications and developments at Pepscan and industry. Subscribe now